CC-401   Click here for help

GtoPdb Ligand ID: 11457

Synonyms: CC401
Compound class: Synthetic organic
Comment: CC-401 was originally identified as a c-Jun N-terminal kinase (JNK) inhibitor. It was developed by Celgene who advanced it into clinical trial for anti-leukemia potential [3], but this programme was abandoned. CC-401 was subsequently found to inhibit DYRK1A and DYRK1B [1]. It promotes replication of pancreatic β-cells in vitro (rat and human) and in vivo (rat) via DYRK1A/B-dependent mechanisms.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 2
Rotatable bonds 6
Topological polar surface area 82.72
Molecular weight 388.2
XLogP 4.5
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C1CCN(CC1)CCOc1cccc(c1)c1n[nH]c2c1cc(cc2)c1[nH]cnn1
Isomeric SMILES C1CCN(CC1)CCOc1cccc(c1)c1n[nH]c2c1cc(cc2)c1[nH]cnn1
InChI InChI=1S/C22H24N6O/c1-2-9-28(10-3-1)11-12-29-18-6-4-5-16(13-18)21-19-14-17(22-23-15-24-27-22)7-8-20(19)25-26-21/h4-8,13-15H,1-3,9-12H2,(H,25,26)(H,23,24,27)
InChI Key XDJCLCLBSGGNKS-UHFFFAOYSA-N
Bioactivity Comments
CC-401 promotes replication of pancreatic β-cells in vitro (rat and human) and in vivo (rat) via DYRK1A/B-dependent mechanisms.
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
maternal embryonic leucine zipper kinase Hs Inhibitor Inhibition 6.5 pIC50 - 2
pIC50 6.5 (IC50 3.4x10-7 M) [2]